Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

Immune checkpoint blockade has greatly improved the clinical outcomes of many patients with metastatic melanoma, however, almost half do not respond. Whether the interspatial distribution of immune and tumor cells predicts response to anti-PD-1-based therapies and patient outcomes in any cancer, inc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Gide, Tuba N., Silva, Ines P., Quek, Camelia, Ahmed, Tasnia, Menzies, Alexander M., Carlino, Matteo S., Saw, Robyn P.M., Thompson, John F., Batten, Marcel, Long, Georgina V., Scolyer, Richard A., Wilmott, James S.
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6959449/
https://ncbi.nlm.nih.gov/pubmed/32002281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1659093
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares